Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mahfoud

Showing results (381-390 of 614) with videos related to

Pageof 62
Sort By:
Journal of Clinical Medicine|June 13, 2025
Non-Invasive Hemodynamic Monitoring in Transcatheter Aortic Valve ImplantationThorald Stolte, Janarthanan Sathananthan, Jakob Johannes Reichl, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2026
Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic SyndromeMert Tokcan, Mathias Hohl, Carolin Victoria Schneider, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2021
Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site locationFelix Mahfoud, Stefan Bertog, Lucas Lauder, et al.
Journal of Molecular and Cellular Cardiology|August 11, 2018
Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndromeSimina-Ramona Selejan, Dominik Linz, Anna-Maria Tatu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 20, 2020
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determinationAlexandra Lansky, Tayyab Shah, William Wijns, et al.
JACC. Cardiovascular Interventions|June 5, 2025
National Estimates of Patient Eligibility for Renal Denervation TherapyNathan W Watson, William B Earle, David E Kandzari, et al.
Heart Rhythm|November 24, 2024
Clinical validation of the 2021 European Society of Cardiology guidelines on preexisting right bundle branch block in patients undergoing transcatheter aortic valve implantationMarc Salis, Patrick Badertscher, Andrea Papa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 9, 2023
Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study designFelix Mahfoud, Michel Azizi, Joost Daemen, et al.
European Journal of Preventive Cardiology|October 27, 2023
Triglyceride-glucose index, low-density lipoprotein levels, and cardiovascular outcomes in chronic stable cardiovascular disease: results from the ONTARGET and TRANSCEND trialsBernhard Haring, Helmut Schumacher, Giuseppe Mancia, et al.
Journal of the American Heart Association|June 15, 2026
Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MEDDavid E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
Pageof 62

Showing results (381-390 of 614) with videos related to

Sort By:
Pageof 62
Journal of Clinical Medicine|June 13, 2025
Non-Invasive Hemodynamic Monitoring in Transcatheter Aortic Valve ImplantationThorald Stolte, Janarthanan Sathananthan, Jakob Johannes Reichl, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2026
Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic SyndromeMert Tokcan, Mathias Hohl, Carolin Victoria Schneider, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2021
Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site locationFelix Mahfoud, Stefan Bertog, Lucas Lauder, et al.
Journal of Molecular and Cellular Cardiology|August 11, 2018
Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndromeSimina-Ramona Selejan, Dominik Linz, Anna-Maria Tatu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 20, 2020
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determinationAlexandra Lansky, Tayyab Shah, William Wijns, et al.
JACC. Cardiovascular Interventions|June 5, 2025
National Estimates of Patient Eligibility for Renal Denervation TherapyNathan W Watson, William B Earle, David E Kandzari, et al.
Heart Rhythm|November 24, 2024
Clinical validation of the 2021 European Society of Cardiology guidelines on preexisting right bundle branch block in patients undergoing transcatheter aortic valve implantationMarc Salis, Patrick Badertscher, Andrea Papa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 9, 2023
Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study designFelix Mahfoud, Michel Azizi, Joost Daemen, et al.
European Journal of Preventive Cardiology|October 27, 2023
Triglyceride-glucose index, low-density lipoprotein levels, and cardiovascular outcomes in chronic stable cardiovascular disease: results from the ONTARGET and TRANSCEND trialsBernhard Haring, Helmut Schumacher, Giuseppe Mancia, et al.
Journal of the American Heart Association|June 15, 2026
Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MEDDavid E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
Pageof 62